本文へ
【全英】ロゴ
S-Quatre
  • Top
    • Science
    • Platform
    • Pipeline
    • News
    • About Us
【全英】検索フォーム
【全英】言語切り替え
JP/EN
【全英】ヘッダーContact
Contact
エディタV2
news news
エディタV2

news

Top | News
お知らせ:カテゴリメニュー
  • 2025年
  • 2024年
お知らせ:表示
  • 2025.10.29
    "Treg" with "SHED" Toward the Development of an Innovative Immune Cell Therapy -Joint Research Agreement with Tokyo University of Science- New
  • 2025.10.16
    Toward a New Infertility Treatment Utilizing SHED - Commencement of Joint Research with LYMPHOGENiX (UK) - 
  • 2025.10.08
    Collaborative Research Results with S-Quatre to be Presented by Nagoya University at the 75th Congress of Neurological Surgeons in Los Angels (CNS 2025)
  • 2025.10.07
    SHED Clinical Study for Cerebral Palsy Data Safety Monitoring Board Confirms "No Safety Concerns"
  • 2025.08.14
    Publication of Research Paper on the Application of SHED in the Treatment of Peripheral Nerve Injuries
  • 2025.08.05
    Featured in Corning’s white paper, our innovative manufacturing technology for SQ-SHED
  • 2025.07.22
    New Results from the joint research with Hamamatsu University School of Medicine to be presented at the 31st Annual Meeting of Japan Society of Gene and Cell Therapy (JSGCT2025)
  • 2025.06.24
    Administration Completed in All Three Patients in Clinical Study Using SHED for the Treatment of Pediatric Cerebral Palsy
  • 2025.06.18
    Joint Presentation on Research Findings Related to Spinal Cord Injury Treatment Using Next-Generation SHED
  • 2025.04.15
    S-Quatre to Present Novel Large-Scale Manufacturing Method for SQ-SHED at ISCT 2025
  • 1
  • 2
  • 次へ

PageTop

【全英】フッターロゴ
S-Quatre

S-Quatre Corporation is a group company of Kidswell Bio Corporation.
Go to Kidswell Bio website.

【全英】フッターリンク
  • Top
  • Science
  • Platform
  • Pipeline
  • News
  • About Us
Contact

© 2024 S-Quatre Corporation